Join the VNAA on November 6 from 12 – 1 p.m. ET (9 – 10 a.m. PT) as Dr. Thomas Mouser, Chief Medical Director of HCI Care Services in West Des Moines, Iowa, provides evidence-based approaches, sound pharmacologic reasoning, and excellent communication techniques to achieve a win-win for clinicians: better outcomes and quality with higher patient satisfaction. Dr. Mouser completed a fellowship in Hospice and Palliative Medicine at Stanford School of Medicine.
Dr. Mouser will provide up-to-date discussion of medications for Hospice and Palliative patients as their illness progresses. Also, he will discuss the importance of having discussions about changing or stopping unnecessary or even harmful medications; and how to work with patients and caregivers to reduce their concern and anxiety. Additionally he will share his in-depth knowledge on managing common distressful symptoms at the end of life.
After completing this training, participants will be able to:
1. Review evidence based rational for reduction in polypharmacy among multiple drug classes
2. Learn key communication techniques to aid in talking with patients about their medications
3. Review mechanisms of iatrogenesis and interaction that can potentiate symptom burden in serious illness
This continuing nursing education activity was approved by the Maryland Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation